Appearance of plasminogen activator activity during a synchronous cycle of a rat adenocarcinoma cell line, PA-III.

[1]  K. Danø,et al.  Plasminogen activator released as inactive proenzyme from murine cells transformed by sarcoma virus. , 2005, European journal of biochemistry.

[2]  D. Belin,et al.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.

[3]  D. Belin,et al.  Concomitant secretion of prourokinase and of a plasminogen activator- specific inhibitor by cultured human monocytes-macrophages , 1984, The Journal of experimental medicine.

[4]  L. Ossowski,et al.  Antibodies to plasminogen activator inhibit human tumor metastasis , 1983, Cell.

[5]  F. Castellino,et al.  Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells. , 1983, Biochemistry.

[6]  E. Wilson,et al.  The secretion of plasminogen activators by human myeloid leukemic cells in vitro. , 1983, Blood.

[7]  B. Norrman,et al.  A sensitive assay for tissue plasminogen activator. , 1982, Thrombosis research.

[8]  D. Loskutoff,et al.  Cultured bovine endothelial cells produce both urokinase and tissue- type plasminogen activators , 1982, The Journal of cell biology.

[9]  L. Ossowski,et al.  A proenzyme form of human urokinase. , 1982, The Journal of biological chemistry.

[10]  C. Kluft,et al.  DEMONSTRATION OF UROKINASE‐RELATED FIBRINOLYTIC ACTIVITY IN HUMAN PLASMA , 1982, British journal of haematology.

[11]  M. Hoylaerts,et al.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. , 1982, The Journal of biological chemistry.

[12]  W. Schleuning,et al.  Isolation and characterization of urokinase from human plasma. , 1982, The Journal of biological chemistry.

[13]  J. Thorell,et al.  Urokinase‐like plasminogen activator as a marker of endometrial neoplasia , 1981, Cancer.

[14]  D. Collen,et al.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.

[15]  D. Rijken,et al.  Relationship between tissue plasminogen activator and the activators in blood and vascular wall. , 1980, Thrombosis research.

[16]  E. Hoal,et al.  Molecular species of plasminogen activators secreted by normal and neoplastic human cells. , 1980, Cancer research.

[17]  G. Markus,et al.  Content and characterization of plasminogen activators in human lung tumors and normal lung tissue. , 1980, Cancer research.

[18]  J. Richie,et al.  Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. , 1980, Cancer research.

[19]  L. Ossowski,et al.  Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue , 1979, Cell.

[20]  A. Kaplan,et al.  Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. , 1977, The Journal of biological chemistry.

[21]  A. Yunis,et al.  Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. , 1977, Biochemistry.

[22]  L. Holmberg,et al.  Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture , 1976, Nature.

[23]  Morris Pollard,et al.  Spontaneous prostate adenocarcinomas in aged germfree Wistar rats. , 1973, Journal of the National Cancer Institute.

[24]  K. Austen,et al.  THE FIBRINOLYTIC PATHWAY OF HUMAN PLASMA , 1972, The Journal of experimental medicine.

[25]  F. Castellino,et al.  Measurement of the binding of antifibrinolytic amino acids to various plasminogens. , 1972, Archives of biochemistry and biophysics.

[26]  K. Robbins,et al.  The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. , 1967, The Journal of biological chemistry.

[27]  Morris Pollard,et al.  Patterns of spontaneous metastasis manifested by three rat prostate adenocarcinomas , 1979, Journal of surgical oncology.

[28]  J. Hamlin,et al.  Animal cell cycle. , 1978, Annual review of biochemistry.

[29]  M. Pollard.  Animal model of human disease: metastic adenocarcinoma of the prostate. , 1977, The American journal of pathology.

[30]  B. Violand,et al.  The effect of ϵ-amino caproic acid on the gross conformation of plasminogen and plasmin , 1975 .